Breaking News Instant updates and real-time market news.

MYOK

MyoKardia

$49.72

-3.45 (-6.49%)

05:15
10/25/18
10/25
05:15
10/25/18
05:15

MyoKardia to create HCM community in collaboration with 23andMe

MyoKardia announced that it has entered into a collaboration with 23andMe to advance research for patients with hypertrophic cardiomyopathy, or HCM, a progressive and frequently debilitating disease characterized by excessive contractility of the heart. MyoKardia is committed to raising awareness and supporting patients and families suffering from this devastating disease, a commitment shared by 23andMe. The goal of this initiative is to deepen disease understanding and build resources intended to benefit patients and their caregivers. Together, the companies will collaborate to improve the baseline understanding of unmet need in the HCM disease area, including patient burden, quality of life, standard of care and variability of symptoms, improve knowledge of disease progression and natural history, and empower patient advocacy. The companies will create a patient community where 23andMe customers can access regularly-updated disease information and HCM research opportunities. More than 6,000 HCM patients are currently 23andMe customers. In addition, a custom survey will be deployed to collect baseline and follow-up longitudinal data from participants with HCM who have opted-in to participate in further research. MyoKardia and 23andMe intend to study this set of de-identified, population-scale phenotypic and genotypic data in order to gain unique insights that may support the broader HCM ecosystem. Summary results will be made available to patients through the 23andMe platform.

  • 30

    Oct

MYOK MyoKardia
$49.72

-3.45 (-6.49%)

10/01/18
CANT
10/01/18
INITIATION
Target $90
CANT
Overweight
MyoKardia initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Alethia Young started MyoKardia with an Overweight rating and $90 price target.
09/28/18
SBSH
09/28/18
INITIATION
Target $90
SBSH
Buy
MyoKardia initiated with a Buy at Citi
Citi analyst Mohit Bansal started MyoKardia with a Buy rating and $90 price target. Early data for the company's lead program Mavacamten in hypertrophic cardiomyopathy indicated significant improvement in obstruction and function, Bansal tells investors in a research note. His analysis and physician checks make him confident around questions of long term safety and efficacy.
09/10/18
MSCO
09/10/18
INITIATION
Target $72
MSCO
Overweight
MyoKardia initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Jeffrey Hung initiated MyoKardia (MYOK) at Overweight with a $72 price target, stating that the obstructive hypertrophic cardiomyopathy Phase 2 data for its lead program, mavacamten, were "robust" and the fact that the company is partnered with Sanofi (SNY) gives him incremental confidence. He expects a mavacamten launch in oHCM in early 2022 and peak U.S. sales for the drug of greater than $1.3B.
08/09/18
WEDB
08/09/18
NO CHANGE
Target $77
WEDB
Outperform
MyoKardia price target raised to $77 from $64 at Wedbush
Wedbush analyst David Nierengarten raised his price target for MyoKardia (MYOK) to $77 from $64 as he now begins to value royalties on potential sales of mavacamten and MYK-491 in Europe based on increasing confidence that Sanofi (SNY) will elect to commercialize there. The analyst is also positive on MyoKardia ahead of the Phase 1b MYK-491 readout in dilated cardiomyopathy later this year, where a favorable safety profile and demonstration of clinical proof of mechanism could add at least $5/share to current levels. He reiterates an Outperform rating on MyoKardia shares.

TODAY'S FREE FLY STORIES

BDX

Becton Dickinson

$245.32

7.2 (3.02%)

17:55
06/20/19
06/20
17:55
06/20/19
17:55
Hot Stocks
Becton Dickinson backs safety of its Lutonix drug-coated balloons in SFA »

BD issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

CPF

Central Pacific

$28.49

-0.13 (-0.45%)

17:41
06/20/19
06/20
17:41
06/20/19
17:41
Hot Stocks
Central Pacific authorizes buyback of up to $30M in common stock »

Central Pacific announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

AEL

American Equity

$27.51

0.3 (1.10%)

17:33
06/20/19
06/20
17:33
06/20/19
17:33
Hot Stocks
American Equity director Debra Richardson sells almost $2.2M in company shares »

American Equity director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$43.68

-0.13 (-0.30%)

17:28
06/20/19
06/20
17:28
06/20/19
17:28
Earnings
Sealed Air backs FY19 adjusted EPS view $2.65-$2.75, consensus $2.73 »

Sealed Air continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$43.68

-0.13 (-0.30%)

17:27
06/20/19
06/20
17:27
06/20/19
17:27
Hot Stocks
Sealed Air names James Sullivan as new CFO, effective June 24 »

Sealed Air announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJRD

Aerojet Rocketdyne

$43.01

1.49 (3.59%)

17:27
06/20/19
06/20
17:27
06/20/19
17:27
Hot Stocks
Aerojet Rocketdyne subsidiary awarded $140.18M missile defense modification »

Coleman Aerospace, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$43.68

-0.13 (-0.30%)

17:25
06/20/19
06/20
17:25
06/20/19
17:25
Hot Stocks
Sealed Air terminates CFO William Stiehl for cause, effective immediately »

Sealed Air announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBU

Brookfield Business Partners

$41.25

1.28 (3.20%)

, BAM

Brookfield

$48.38

0.29 (0.60%)

17:15
06/20/19
06/20
17:15
06/20/19
17:15
Syndicate
Brookfield Business Partners announces $795M equity offering »

Brookfield Business…

BBU

Brookfield Business Partners

$41.25

1.28 (3.20%)

BAM

Brookfield

$48.38

0.29 (0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

AXLA

Axcella

$10.39

0.27 (2.67%)

17:13
06/20/19
06/20
17:13
06/20/19
17:13
Earnings
Axcella reports Q1 EPS ($2.43), consensus (49c) »

Q1 operating expenses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LKSD

LSC Communications

$5.83

0.07 (1.22%)

17:11
06/20/19
06/20
17:11
06/20/19
17:11
Hot Stocks
LSC comments on DOJ action regarding proposed transaction with Quad »

LSC Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUAD

Quad/Graphics

$9.75

0.09 (0.93%)

, LKSD

LSC Communications

$5.83

0.07 (1.22%)

17:10
06/20/19
06/20
17:10
06/20/19
17:10
Hot Stocks
Quad/Graphics intends to defend proposed LSC Communications acquisition »

Quad/Graphics (QUAD)…

QUAD

Quad/Graphics

$9.75

0.09 (0.93%)

LKSD

LSC Communications

$5.83

0.07 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFM

Sprouts Farmers Market

$19.52

0.14 (0.72%)

17:04
06/20/19
06/20
17:04
06/20/19
17:04
Hot Stocks
Sprouts Farmers Market interim co-CEO/CFO Brad Lukow resigns »

Sprouts Farmers Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NAKD

Naked Brand Group

$0.27

0.0025 (0.93%)

17:03
06/20/19
06/20
17:03
06/20/19
17:03
Syndicate
Breaking Syndicate news story on Naked Brand Group »

Naked Brand Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPQ

HP Inc.

$20.85

0.22 (1.07%)

16:57
06/20/19
06/20
16:57
06/20/19
16:57
Hot Stocks
HP Inc. General Counsel sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 01

    Jul

  • 02

    Jul

  • 03

    Jul

  • 04

    Jul

CPT

Camden Property

$107.61

0.57 (0.53%)

16:54
06/20/19
06/20
16:54
06/20/19
16:54
Hot Stocks
Camden Property COO sells 16.2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COMM

CommScope

$16.00

0.38 (2.43%)

16:52
06/20/19
06/20
16:52
06/20/19
16:52
Hot Stocks
CommScope's distributed antenna system patents upheld in favorable ruling »

CommScope received…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

INVH

Invitation Homes

$27.68

-0.07 (-0.25%)

16:50
06/20/19
06/20
16:50
06/20/19
16:50
Syndicate
Invitation Homes announces offering of 37.5M shares of common stock for holders »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGY

VAALCO Energy

$1.55

0.03 (1.97%)

16:46
06/20/19
06/20
16:46
06/20/19
16:46
Hot Stocks
VAALCO Energy announces $10M stock buyback program »

VAALCO Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTG

Entegris

$38.50

1.36 (3.66%)

, INTC

Intel

$47.16

0.08 (0.17%)

16:45
06/20/19
06/20
16:45
06/20/19
16:45
Initiation
Entegris, Intel, TSMC initiated  »

Entegris initiated with a…

ENTG

Entegris

$38.50

1.36 (3.66%)

INTC

Intel

$47.16

0.08 (0.17%)

TSM

TSMC

$40.52

1.11 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

16:38
06/20/19
06/20
16:38
06/20/19
16:38
General news
Money Supply M2 Weekly Change data reported »

Week of 6/10 Money Supply…

LH

LabCorp

$168.01

-1.54 (-0.91%)

16:37
06/20/19
06/20
16:37
06/20/19
16:37
Upgrade
LabCorp rating change at Deutsche Bank »

LabCorp upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

FNKO

Funko

$24.25

2.02 (9.09%)

16:35
06/20/19
06/20
16:35
06/20/19
16:35
Initiation
Funko initiated  »

Funko initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

HSIC

Henry Schein

$70.96

-1.06 (-1.47%)

16:35
06/20/19
06/20
16:35
06/20/19
16:35
Hot Stocks
Henry Schein CFO Steven Paladino sells almost $1.5M in company shares »

Henry Schein CFO Steven…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:34
06/20/19
06/20
16:34
06/20/19
16:34
General news
Fed Balance Sheet Level data reported »

Week of 6/19 Fed Balance…

CTRV

ContraVir Pharmaceuticals

$4.27

-0.485 (-10.21%)

16:34
06/20/19
06/20
16:34
06/20/19
16:34
Hot Stocks
ContraVir Pharma receives positive FDA response to NASH candidate plans »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.